CXMT's Shanghai debut is not just a big Chinese chip listing. It is a live test of whether Beijing can turn the AI memory shortage into a domestic semiconductor champion while US controls keep tightening.
ChangXin Memory Technologies, better known as CXMT, began trading on Shanghai's STAR Market on July 27 after pricing shares at 8.66 yuan and raising about 57.9 billion yuan, roughly $8.6 billion. Reuters reported the offer price and fundraising figure earlier this month, and TrendForce, citing MoneyDJ and Securities Times, said the deal would overtake SMIC's 2020 listing to become the largest IPO in STAR Market history. That correction matters. This is not the second-biggest debut on the board. It is the new record.
The numbers are blunt. CXMT's implied market value at listing is about 579 billion yuan, or around $85 billion. Retail investors subscribed for more than 200 times the shares available to them, according to a Reuters report based on exchange filings, while institutional investors put in orders equal to roughly 570 times the shares on offer. Demand was not quiet. It was crowded.
Most Western investors could barely have named CXMT a year ago. They can now.
The company is based in Hefei, Anhui province, and makes DRAM, the working memory used in PCs, smartphones, servers and AI systems. South China Morning Post, citing CXMT's prospectus, reported that first-quarter revenue reached 50.8 billion yuan, about $7.4 billion, up 719% from a year earlier, while net profit swung to 33 billion yuan from a loss of 2.83 billion yuan. That is not a small domestic substitute limping along behind Samsung, SK Hynix and Micron. It is a state-backed Chinese memory maker arriving at exactly the moment memory is scarce.
AI gave CXMT the window
The timing is the story. AI infrastructure build-outs have pushed DRAM demand higher, especially as data centers absorb more memory for servers and accelerators. You don't need to dress that up. Scarcity gave CXMT pricing power, and the IPO gave it cash.
The company originally planned to raise 29.5 billion yuan for investment projects, according to Chinese state media and prospectus summaries, but the final base offering brought in almost twice that amount before any greenshoe option. CXMT now has a war chest for capacity and process upgrades at a moment when Chinese customers want an alternative supply line and Beijing wants proof that years of semiconductor subsidies can produce more than slogans.
There is still a ceiling. The United States has restricted exports of advanced chipmaking equipment to China since October 2022, including tools used for advanced DRAM production. ASML's most advanced lithography equipment remains beyond CXMT's reach. In April 2026, US senators introduced the MATCH Act, which specifically named CXMT, YMTC, SMIC, Huawei and Hua Hong facilities for tougher equipment and servicing restrictions. In June, the Defense Department's updated Section 1260H list again identified CXMT as a Chinese military company operating directly or indirectly in the United States.
That designation does not stop CXMT from selling DRAM in China. It does make the foreign route harder, especially for customers with US exposure. Frankly, that is the tension investors are buying into: CXMT has the demand, the capital and the political backing, but the best equipment remains guarded by Washington and its allies.
The market felt the weight
A listing this large also pulls money from somewhere. Reuters reported that Chinese tech shares sold off before the debut as investors worried the IPO would drain liquidity from secondary markets. Caixin put a sharper number on the pressure: retail investors had to settle 33.3 billion yuan of CXMT IPO allocations on July 21, while tech hardware sectors saw more than 23 billion yuan in net outflows that day.
That is what a mega-cap listing does in a retail-heavy market. It becomes a gravity well. Some investors sell what they already own so they can chase what is coming next, and crowded semiconductor trades take the hit first.
Look at the float, too. Reuters reported CXMT planned to issue 6.69 billion new shares, equal to about 10% of enlarged share capital, with a 15% overallotment option available. A record deal with a limited tradable supply can move violently in its first sessions. The first-day price is interesting, but it is not the real test.
The real test is whether CXMT can keep its margins once the memory cycle cools. Morningstar Asia recently estimated that CXMT's wafer capacity could reach 325,000 wafer starts per month by the end of 2026, still roughly one-sixth of the combined projected capacity of the three global memory leaders. The same analysis said CXMT remains meaningfully behind peers in technology. That is the sober part of the story, and it is exactly why the $8.6 billion raise matters.
Don't let the caveats bury the event. A Chinese DRAM maker just pulled off Asia's biggest IPO of 2026, set a STAR Market fundraising record, and did it while US policy is aimed at slowing precisely this kind of semiconductor climb. CXMT has not caught Samsung or SK Hynix. It has forced the market to take its attempt seriously.
Also read: Chinese biotech is stealing the emerging market trade that AI dominated for two years • Nvidia bets $1.5 billion on Amkor to break its chip packaging bottleneck • TSMC beat every earnings record and Wall Street sold the stock anyway
